Evidence map›Paper›PMID 42050148›Full record

ArticleNature cell biology2026

Author Correction: A complex secretory program orchestrated by the inflammasome controls paracrine senescence.

Juan Carlos Acosta, Ana Banito, Torsten Wuestefeld, Athena Georgilis, Peggy Janich, Jennifer P Morton, Dimitris Athineos, Tae-Won Kang, Felix Lasitschka, Mindaugas Andrulis and 15 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Juan Carlos Acosta *Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.
Ana Banito *Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.
Torsten WuestefeldDivision of Translational Gastrointestinal Oncology, Department of Internal Medicine I, Eberhard Karls University Tübingen, Tübingen, Germany.
Athena GeorgilisCell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.
Peggy JanichCenter for Genomic Regulation and UPF, Barcelona, Spain.
Jennifer P MortonThe Beatson Institute for Cancer Research, Glasgow, UK.
Dimitris AthineosThe Beatson Institute for Cancer Research, Glasgow, UK.
Tae-Won KangDivision of Translational Gastrointestinal Oncology, Department of Internal Medicine I, Eberhard Karls University Tübingen, Tübingen, Germany.
Felix LasitschkaInstitute of Pathology, University of Heidelberg, and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Mindaugas AndrulisInstitute of Pathology, University of Heidelberg, and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Gloria PascualCenter for Genomic Regulation and UPF, Barcelona, Spain.
Kelly J MorrisCell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.
Sadaf KhanCell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.
Hong JinDepartment of Biochemistry, University of Leicester, Leicester, UK.
Gopuraja DharmalingamEpigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.
Ambrosius P SnijdersProteomics Facility, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.
Thomas CarrollEpigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.
David CapperInstitute of Pathology, University of Heidelberg, and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Catrin PritchardDepartment of Biochemistry, University of Leicester, Leicester, UK.
Gareth J InmanMedical Research Institute, University of Dundee, Dundee, UK.
Thomas LongerichInstitute of Pathology, University of Heidelberg, and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Owen J SansomThe Beatson Institute for Cancer Research, Glasgow, UK.
Salvador Aznar BenitahCenter for Genomic Regulation and UPF, Barcelona, Spain.
Lars ZenderDivision of Translational Gastrointestinal Oncology, Department of Internal Medicine I, Eberhard Karls University Tübingen, Tübingen, Germany.
Jesús GilCell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK. jesus.gil@csc.mrc.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42050148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.